Atezolizumab Plus Etoposide and Platinum for Bladder Cancer
Phase 2
63
about 7.4 years
18+
2 sites in DC, MD
What this study is about
This trial is testing a treatment with atezolizumab, platinum, and etoposide in people with bladder cancer. The goal is to see if the combination therapy leads to a pathologic complete response after cystectomy.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Atezolizumab
- 2.Take Carboplatin
- 3.Take Cisplatin
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
atezolizumab, carboplatin, cisplatin (Platinum chemotherapy; crosslinks DNA to stop replication), etoposide
injection (Injection), injection, intravenous
Secondary: 1-year overall survival rate (1-yr OS), 2-year overall survival rate (2-yr OS), Disease Free Survival, Safety and tolerability of combination chemotherapy and cystectomy as assessed by number of participants experiencing adverse events
Oncology